Last reviewed · How we verify
Ritlecitinib 100 mg (ritlecitinib-100-mg)
Ritlecitinib 100 mg (generic name: ritlecitinib-100-mg) is a drug developed by Pfizer Inc.. It is currently in Phase 2 development.
At a glance
| Generic name | ritlecitinib-100-mg |
|---|---|
| Sponsor | Pfizer Inc. |
| Phase | Phase 2 |
Approved indications
Common side effects
- Atrioventricular block first degree
- Vessel puncture site pain
- Arthralgia
- Abdominal pain
- Diarrhoea
- Chills
- Folliculitis
- Pain in extremity
- Erythema
- Night sweats
- Pruritus
- Haematoma
Key clinical trials
- A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2 (PHASE3)
- A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults. (PHASE2)
- A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata (PHASE3)
- A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo (PHASE3)
- A Study to Learn About Three Forms of The Study Medicine (Ritlecitinib) in Healthy Adults (PHASE1)
- A Study to Learn About How Different Forms of the Study Medicine Called Ritlecitinib Pass the Intestines of Healthy Male Adults When Taken With or Without Food (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ritlecitinib 100 mg CI brief — competitive landscape report
- Ritlecitinib 100 mg updates RSS · CI watch RSS
- Pfizer Inc. portfolio CI
Frequently asked questions about Ritlecitinib 100 mg
What is Ritlecitinib 100 mg?
Ritlecitinib 100 mg (ritlecitinib-100-mg) is a pharmaceutical drug developed by Pfizer Inc..
Who makes Ritlecitinib 100 mg?
Ritlecitinib 100 mg is developed by Pfizer Inc. (see full Pfizer Inc. pipeline at /company/pfizer).
What is the generic name of Ritlecitinib 100 mg?
ritlecitinib-100-mg is the generic (nonproprietary) name of Ritlecitinib 100 mg.
What development phase is Ritlecitinib 100 mg in?
Ritlecitinib 100 mg is in Phase 2.
What are the side effects of Ritlecitinib 100 mg?
Common side effects of Ritlecitinib 100 mg include Atrioventricular block first degree, Vessel puncture site pain, Arthralgia, Abdominal pain, Diarrhoea, Chills.
Related
- Manufacturer: Pfizer Inc. — full pipeline
- Compare: Ritlecitinib 100 mg vs similar drugs
- Pricing: Ritlecitinib 100 mg cost, discount & access